| Thomas Chittenden Health Center, Plc | |
|
586 Oak Hill Road Williston VT 05495-7103 | |
| (802) 878-8131 | |
| (802) 879-6853 |
| Full Name | Thomas Chittenden Health Center, Plc |
|---|---|
| Speciality | Family Medicine |
| Location | 586 Oak Hill Road, Williston, Vermont |
| Authorized Official Name and Position | Rachel Atkins (BUSINESS MANAGER) |
| Authorized Official Contact | 8028788131 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Chittenden Health Center, Plc 586 Oak Hill Road Williston VT 05495-7103 Ph: (802) 878-8131 | Thomas Chittenden Health Center, Plc 586 Oak Hill Road Williston VT 05495-7103 Ph: (802) 878-8131 |
| NPI Number | 1811099229 |
|---|---|
| Provider Enumeration Date | 09/05/2006 |
| Last Update Date | 06/11/2013 |
| Medicare PECOS PAC ID | 7012813322 |
|---|---|
| Medicare Enrollment ID | O20031209000188 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811099229 | NPI | - | NPPES |
| 0VN1591 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| Provider Name | Pamela J Dawson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1174631915 PECOS PAC ID: 0042116378 Enrollment ID: I20031209000277 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Maryanne Kyburz Ladue |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1700840600 PECOS PAC ID: 5092759878 Enrollment ID: I20050613000912 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Kristen C Bolton |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1750465746 PECOS PAC ID: 8325083884 Enrollment ID: I20050624000344 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Patricia A Towle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669452835 PECOS PAC ID: 8022039585 Enrollment ID: I20051212000699 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Harley D Donnelly |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1417967787 PECOS PAC ID: 6406864982 Enrollment ID: I20060324000178 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Jeffrey Erik Haddock |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1861418782 PECOS PAC ID: 4082711486 Enrollment ID: I20070519000030 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | David N Simcoe |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1225011208 PECOS PAC ID: 9032153853 Enrollment ID: I20081229000204 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Joseph H Haddock |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1831206564 PECOS PAC ID: 0840100251 Enrollment ID: I20100614000579 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Adriane C Trout |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1144246331 PECOS PAC ID: 8628070968 Enrollment ID: I20130419000135 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Nina H Gaby |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477850030 PECOS PAC ID: 6608194246 Enrollment ID: I20150413000149 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Jack E Visco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497119978 PECOS PAC ID: 0345531448 Enrollment ID: I20160621001320 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Lily Stolberg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831606326 PECOS PAC ID: 0648533067 Enrollment ID: I20180418001379 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Mirsada Nurkanovic |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831685767 PECOS PAC ID: 2860743846 Enrollment ID: I20181002000895 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Adrienne R Jarvis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1629573282 PECOS PAC ID: 5698039220 Enrollment ID: I20210823002063 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Mei-lani Bixby |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457692691 PECOS PAC ID: 3173997020 Enrollment ID: I20230316001850 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Katharine Ann Stones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154045714 PECOS PAC ID: 9436511193 Enrollment ID: I20230811000685 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
| Provider Name | Anastasiya Lulic |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164208377 PECOS PAC ID: 7315398625 Enrollment ID: I20240111001813 |
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
News Archive
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announced today that it has been awarded a cash grant totaling $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Navigated Brian Stimulation System for use in the assessment of the primary motor cortex for pre-procedural planning.
The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.
Fredrick Junn, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the Medical field.
› Verified 7 days ago
Adult Medicine Partners - Vermont Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 66 Knight Ln Ste 10, Williston, VT 05495 Phone: 802-872-4343 Fax: 802-872-0907 | |
Vermont Center For Regenerative Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 71 Knight Ln Ste 20, Williston, VT 05495 Phone: 802-734-9455 Fax: 678-574-5605 | |
Tina D'amato, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 71 Knight Ln, Suite 10/20, Williston, VT 05495 Phone: 802-872-7001 Fax: 802-872-9088 | |
Family Medicine Partners - Vermont Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 66 Knight Ln Ste 10, Williston, VT 05495 Phone: 802-872-4343 Fax: 802-872-0907 | |
Evergreen Family Health Partners Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 28 Park Ave, Williston, VT 05495 Phone: 802-878-1008 Fax: 802-872-2679 | |
Thomas Chittenden Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 586 Oak Hill Rd, Williston, VT 05495 Phone: 802-878-8131 |